Slide 1I-PRESERVE Trial Irbesartan in heart failure with preserved EF Co-PIs: Peter Carson and Barry Massie Executive Committee M. Komajda, R. McKelvie, J. McMurray, M. Zile,…

Slide 1HFSA 2010 Comprehensive Heart Failure Practice Guideline Key Recommendations Slide 2 Lindenfeld J, et al. HFSA 2010 Comprehensive Heart Failure Guideline. J Card Fail…

Slide 1Left Ventricular Dyssynchrony and Cardiac Resynchronization Therapy in Heart Failure Airley E. Fish MD Imaging Conference August 19 th 2009 Slide 2 Outline Introduction…

Slide 1LV Dssynchrony and Cardiac Resynchronization Therapy in Heart Failure Nisha I. Parikh MD MPH August 13 th 2008 Slide 2 Summary of Talk Background CRT Rational and…

Slide 1 Trial to Assess Chelation Therapy (TACT) Principal Investigator: Gervasio A. Lamas, MD Mount Sinai Medical Center – Miami Heart Institute Miami Beach FL Slide 2…

Slide 1 By: Ellinor Lagerberg Slide 2  Gain knowledge about CHF (congestive heart failure) and its etiology.  To understand how nutrition education is applied in acute…

Highlights in ischaemic cardiovascular disease Doc dr Amra Džanković Results from KYOTO HEART study Designed to examine the effects of valsartan as an add-on to conventional…

PROCORALAN Effect of ivabradine on composite of CV death or HF hospitalization 0 0 6 12 18 24 30 10 20 30 40 50 Patients (%) Time (months) Ivabradine, renal dysfunction Placebo,…

Highlights in ischaemic cardiovascular disease Doc dr Amra Džanković Results from KYOTO HEART study Designed to examine the effects of valsartan as an add-on to conventional…

Chuck Kitchen, MA, FAACVPR [email protected] http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=270 NCD 20:10 Effective date: February…